Latest news

Nxera doubles down on obesity drugs as Pfizer, Novo and Terns exit GLP-1 candidates

Nxera doubles down on obesity drugs as Pfizer, Novo and Terns exit GLP-1 candidates

Joachim Eeckhout
Daily Snap - 6. August 2025

Daily Snap - 6. August 2025

Joachim Eeckhout
SERB buys Y-mAbs for $412M to expand rare cancer pipeline

SERB buys Y-mAbs for $412M to expand rare cancer pipeline

Joachim Eeckhout
HHS halts $500M in mRNA vaccine projects under Kennedy’s directive

HHS halts $500M in mRNA vaccine projects under Kennedy’s directive

Joachim Eeckhout
Daily Snap - 5. August 2025

Daily Snap - 5. August 2025

Joachim Eeckhout
Xoma scoops up struggling biotechs HilleVax and Lava in bargain deals

Xoma scoops up struggling biotechs HilleVax and Lava in bargain deals

Joachim Eeckhout
Praxis touts epilepsy drug gains despite 23% dropout rate

Praxis touts epilepsy drug gains despite 23% dropout rate

Joachim Eeckhout
Daily Snap - 17. July 2025

Daily Snap - 17. July 2025

Joachim Eeckhout
Sarepta slashes workforce, scales back research after Duchenne gene therapy setbacks

Sarepta slashes workforce, scales back research after Duchenne gene therapy setbacks

Joachim Eeckhout
Otsuka continues its bet on autoimmune therapies with $613M Cantargia antibody deal

Otsuka continues its bet on autoimmune therapies with $613M Cantargia antibody deal

Joachim Eeckhout
WHO adds ArkBio ́s RSV drug to its priority list

WHO adds ArkBio ́s RSV drug to its priority list

Eduardo Longoria
AstraZeneca’s new blood pressure drug bought from CinCor clears major trial

AstraZeneca’s new blood pressure drug bought from CinCor clears major trial

Joachim Eeckhout
FirstBack
1314151617181920
Next Last